Why IRON was halted on Oct 19 2026: phase 3 results
IRON+26.0%on Mon Oct 19 2026
Disc Medicine, Inc. Common Stock was up 26.0% on the day at $71.60, ranked #17 on 36.5× its usual five-minute volume, when TapeRank recorded this trading halt at 06:56 ET during the pre-market session when it was halted. TapeRank recorded 2 events for IRON that day, between 05:14 and 06:56 ET, and each is in the timeline below.
THE DAY ON THE LIST · 2 EVENTS
- 05:14 ETMOVER · PRE-MARKET
$75.20 · ▲ 32.3% ON THE DAY · 73.4× 5M RVOL · RANK #6
No verdict was committed for this event.
THE ROW AND SESSION LEVELS AT 05:14 ET
LAST75.20DAY▲ 32.3%5 MIN▲ 0.94%5M RVOL73.4×5M $VOL$521KFLOAT*38.4MRANK#6SESSIONPRE-MARKETVWAP73.32HOD75.31LOD69.00OR HIGH—OR LOW—PREV CLOSE56.84PM HIGH75.31PM LOW69.00GAP▲ 32.30% (indicated)* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO
- 06:56 ETHALT · PRE-MARKET
HALTED AT $71.60 · ▲ 26.0% ON THE DAY · 36.5× 5M RVOL · RANK #17
JUSTIFIEDCONFIDENCE4/5IRON is up 26.0% pre-market ahead of topline Phase 3 APOLLO trial results for bitopertin in erythropoietic protoporphyria. The pending-news trading halt indicates the move is event-driven, and a major Phase 3 readout plausibly supports a move of this size.
WHYA 26% pre-market move is large, but proportionate to an imminent Phase 3 topline-results announcement with trading halted for news pending.ANALYZED 06:58 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNATHE ROW AND SESSION LEVELS AT 06:56 ET
LAST71.60DAY▲ 26.0%5 MIN▲ 2.29%5M RVOL36.5×5M $VOL$232KFLOAT*38.4MRANK#17SESSIONPRE-MARKETVWAP75.09HOD81.99LOD68.95OR HIGH—OR LOW—PREV CLOSE56.84PM HIGH81.99PM LOW68.95GAP▲ 25.97% (indicated)* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO
NO VERDICT MEANS THE MODEL HAD NOT REACHED THE NAME BEFORE THE EVENT WAS FINALIZED, OR ITS ANSWER HEDGED AND WAS WITHHELD. NOTHING WAS FILLED IN AFTERWARDS.
THE SESSION
- 06:55 ETHalted (T1); resumed 07:20 ET, after 24 minutes
- 09:30 ETOpened at $72.70, +27.9% on the previous close of $56.84
- 09:46 ETRegular-session low, $69.98
- 11:00 ETRegular-session high, $80.22
- 15:59 ETLast trade of the regular session, $78.98, +39.0% on the previous close of $56.84
- Volume: 6.8M shares in regular hours, 1.3M before the open
IRON opened at $72.70 after reaching $75.20 pre-market, then dipped to $69.98 before climbing to a regular-session high of $80.22 and ending at $78.98, up 39.0% from the previous close. TapeRank read the move as justified by the pending Phase 3 APOLLO trial results for bitopertin in erythropoietic protoporphyria, citing the company’s webcast announcement and the news-pending halt as support for an event-driven move; the halt resumed at 07:20 ET after 24 minutes.
WRITTEN MON OCT 19 2026 16:00 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE
FILINGS AND NEWS · 24H BEFORE THE MOVE
On the tape right now
WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY
Open the full list